Corcept Therapeutics(CH:HTD)
CH:HTD
Corcept Therapeutics Revenue
Corcept Therapeutics (HTD) Revenue
0 Followers
Corcept Therapeutics Revenue
Corcept Therapeutics had a revenue of 340.47M in the quarter ending Sep 30, 2026, with 32.92%. This bring the company's revenue in the last twelve months to 963.65M, Increased 15.99%. In the fiscal year ending Dec 31, 2025, Corcept Therapeutics had annual revenue of 761.41M with 12.79% growth.
- Revenue (ttm)
- 963.65M
- Revenue Growth
- 22.61%
- P/S Ratio
- 8.77
- Revenue/Employee
- CHF 1,043,023
- Employees
- 730
- Market Cap
- CHF 6.68B
Revenue Chart
Corcept Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 761.41M | 86.37M | 12.79% |
| Dec 31, 2024 | 675.04M | 192.66M | 39.94% |
| Dec 31, 2023 | 482.38M | 80.52M | 20.04% |
| Dec 31, 2022 | 401.86M | 35.88M | 9.80% |
| Dec 31, 2021 | 365.98M | 12.10M | 3.42% |
| Dec 31, 2020 | 353.87M | 47.39M | 15.46% |
| Dec 31, 2019 | 306.49M | 55.24M | 21.99% |
| Dec 31, 2018 | 251.25M | 92.05M | 57.82% |
| Dec 31, 2017 | 159.20M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.